E-Cigarette Use, Systemic Inflammation, and Depression.
Individual Clinical
Safety
Adverse Effects
Farrell (2021)
Passive exposure to e-cigarette emissions is associated with worsened mental health.
Individual Clinical
Safety
Adverse Effects
Farrell (2022)
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review
Individual Clinical
Safety
Adverse Effects
Farsalinos (2014)
Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and na"ive users (smokers)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Farsalinos (2015)
Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes
Individual Clinical
Biomarkers
Farsalinos (2016)
E-cigarettes emit very high formaldehyde levels only in conditions that are aversive to users: a replication study under verified realistic use conditions
Individual Clinical
User Topography
Farsalinos (2017)
adverse Experience Reports of Seizures in Youth and Young adult Electronic Nicotine Delivery Systems Users.
Individual Clinical
Safety
Adverse Effects
Faulcon (2020)
human abuse liability assessment of e-cigarettes: Why, what and how?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Fearon (2022)
a randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2022)
Short-Term abstinence Effects in Experienced Electronic Cigarette Users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Felicione (2019)